Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Groove Botanicals (GRVE) EPS (Weighted Average and Diluted) (2016 - 2025)

Groove Botanicals' EPS (Weighted Average and Diluted) history spans 4 years, with the latest figure at -$0.01 for Q4 2016.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 20.0% to -$0.01 in Q4 2016 year-over-year; TTM through Dec 2016 was -$0.03, a 133.33% decrease, with the full-year FY2025 number at -$0.01, changed 0.0% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.01 in Q4 2016 for Groove Botanicals, down from -$0.0 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for GRVE hit a ceiling of $0.0 in Q4 2014 and a floor of -$0.02 in Q4 2013.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.01 across 4 years, with a median of -$0.01 in 2015.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 127.75% in 2014 and later plummeted 300.0% in 2015.
  • Tracing GRVE's EPS (Weighted Average and Diluted) over 4 years: stood at -$0.02 in 2013, then soared by 127.75% to $0.0 in 2014, then plummeted by 300.0% to -$0.01 in 2015, then increased by 20.0% to -$0.01 in 2016.
  • Business Quant data shows EPS (Weighted Average and Diluted) for GRVE at -$0.01 in Q4 2016, -$0.0 in Q3 2016, and -$0.0 in Q2 2016.